ProfileGDS4095 / 220104_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 88% 84% 87% 88% 86% 84% 80% 80% 76% 77% 79% 77% 79% 80% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep110.316488
GSM709769LY2 SRC1-siRNA tamoxifen treated rep39.5757584
GSM709765LY2 SRC1-siRNA untreated rep39.9941287
GSM709771LY2 SRC1-siRNA untreated rep110.260788
GSM709772LY2 SRC1-siRNA untreated rep29.8041786
GSM709775LY2 SRC1-siRNA untreated rep49.5571784
GSM709764LY2 control-siRNA tamoxifen treated rep28.7891780
GSM709766LY2 control-siRNA tamoxifen treated rep38.8527880
GSM709768LY2 control-siRNA tamoxifen treated rep17.9709976
GSM709777LY2 control-siRNA tamoxifen treated rep48.1430577
GSM709770LY2 control-siRNA untreated rep38.602379
GSM709773LY2 control-siRNA untreated rep18.2707477
GSM709774LY2 control-siRNA untreated rep28.5506479
GSM709776LY2 control-siRNA untreated rep48.7433180